|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2008-4-18
|
|
pubmed:abstractText |
Taxanes (paclitaxel or docetaxel) have been sequenced or combined with anthracyclines (doxorubicin or epirubicin) for the first-line treatment of advanced breast cancer. This meta-analysis uses data from all relevant trials to detect any advantages of taxanes in terms of tumor response, progression-free survival (PFS), and survival.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:BasaranGul AtalayGA,
pubmed-author:BiganzoliLauraL,
pubmed-author:BonneterreJacquesJ,
pubmed-author:BontenbalMarijkeM,
pubmed-author:BurzykowskiTomaszT,
pubmed-author:BuyseMarcM,
pubmed-author:CarmichaelJamesJ,
pubmed-author:ChanStephenS,
pubmed-author:JassemJacekJ,
pubmed-author:LückHans-JoachimHJ,
pubmed-author:MackeyJohn RJR,
pubmed-author:NabholtzJean-MarcJM,
pubmed-author:ParidaensRobertR,
pubmed-author:Piccart-GebhartMartine JMJ,
pubmed-author:SledgeGeorgeG,
pubmed-author:TherassePatrickP
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1980-6
|
|
pubmed:meshHeading |
pubmed-meshheading:18421049-Anthracyclines,
pubmed-meshheading:18421049-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18421049-Breast Neoplasms,
pubmed-meshheading:18421049-Disease-Free Survival,
pubmed-meshheading:18421049-Female,
pubmed-meshheading:18421049-Humans,
pubmed-meshheading:18421049-Neoplasm Metastasis,
pubmed-meshheading:18421049-Proportional Hazards Models,
pubmed-meshheading:18421049-Randomized Controlled Trials as Topic,
pubmed-meshheading:18421049-Survival Rate,
pubmed-meshheading:18421049-Taxoids
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer.
|
|
pubmed:affiliation |
Institut Jules Bordet, 121 boulevard de Waterloo, 1000 Brussels, Belgium. martine.piccart@bordet.be
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|
